213 related articles for article (PubMed ID: 28207540)
1. Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.
Liu C; Lu Q; Qu H; Geng L; Bian M; Huang M; Wang H; Zhang Y; Wen Z; Zheng S; Zhang Z
Medicine (Baltimore); 2017 Feb; 96(7):e6124. PubMed ID: 28207540
[TBL] [Abstract][Full Text] [Related]
2. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative treatment of uterine fibroids with low-dose mifepristone: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study].
Bian ML; Huang ML; Zhang ZY; Liu SM; Sun J; Fang F; Gu YP; Liu CD; Yao C
Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):317-327. PubMed ID: 34034418
[No Abstract] [Full Text] [Related]
4. Progesterone receptor modulators for endometriosis.
Fu J; Song H; Zhou M; Zhu H; Wang Y; Chen H; Huang W
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009881. PubMed ID: 28742263
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of uterine leiomyoma by two different doses of mifepristone].
Yang Y; Zheng S; Li K
Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):624-6. PubMed ID: 9275461
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of mifepristone for the treatment of uterine leiomyomata.
Steinauer J; Pritts EA; Jackson R; Jacoby AF
Obstet Gynecol; 2004 Jun; 103(6):1331-6. PubMed ID: 15172874
[TBL] [Abstract][Full Text] [Related]
7. Treatment of uterine myoma with 5 or 10mg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trial.
Esteve JL; Acosta R; Pérez Y; Campos R; Hernández AV; Texidó CS
Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):202-8. PubMed ID: 22269473
[TBL] [Abstract][Full Text] [Related]
8. Network meta-analysis of 6 kinds of Chinese patent medicines combined with mifepristone in the treatment of uterine fibroids: A protocol for systematic review and network meta-analysis.
Bi C; Qiao M; Jia Y; Wang H
Medicine (Baltimore); 2021 Oct; 100(42):e27523. PubMed ID: 34678886
[TBL] [Abstract][Full Text] [Related]
9. Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial.
Che X; Wang J; Sun W; He J; Wang Q; Zhu D; Zhu W; Zhang J; Dong J; Xu J; Zheng F; Zhou J; Zhao W; Lin Q; Ye L; Zhao X; Xu Z; Chen Y; Wang J; Wu W; Zhai L; Zhou Y; Zheng J; Zhang X
JAMA Netw Open; 2023 Jun; 6(6):e2317860. PubMed ID: 37307001
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
Stolz W; Pfützenreuter N
Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
[TBL] [Abstract][Full Text] [Related]
11. Low-dose mifepristone for uterine leiomyomata.
Eisinger SH; Meldrum S; Fiscella K; le Roux HD; Guzick DS
Obstet Gynecol; 2003 Feb; 101(2):243-50. PubMed ID: 12576246
[TBL] [Abstract][Full Text] [Related]
12. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.
Eisinger SH; Fiscella J; Bonfiglio T; Meldrum S; Fiscella K
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):215-8. PubMed ID: 19586708
[TBL] [Abstract][Full Text] [Related]
13. Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.
Fiscella K; Eisinger SH; Meldrum S; Feng C; Fisher SG; Guzick DS
Obstet Gynecol; 2006 Dec; 108(6):1381-7. PubMed ID: 17138770
[TBL] [Abstract][Full Text] [Related]
14. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
15. Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone.
Feng C; Meldrum S; Fiscella K
Int J Gynaecol Obstet; 2010 May; 109(2):121-4. PubMed ID: 20132932
[TBL] [Abstract][Full Text] [Related]
16. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.
Yerushalmi GM; Gilboa Y; Jakobson-Setton A; Tadir Y; Goldchmit C; Katz D; Seidman DS
Fertil Steril; 2014 Feb; 101(2):496-500. PubMed ID: 24220703
[TBL] [Abstract][Full Text] [Related]
17. Low dose mifepristone in medical management of uterine leiomyoma - an experience from a tertiary care hospital from north India.
Kulshrestha V; Kriplani A; Agarwal N; Sareen N; Garg P; Hari S; Thulkar J
Indian J Med Res; 2013 Jun; 137(6):1154-62. PubMed ID: 23852296
[TBL] [Abstract][Full Text] [Related]
18. Herbal preparations for uterine fibroids.
Liu JP; Yang H; Xia Y; Cardini F
Cochrane Database Syst Rev; 2013 Apr; (4):CD005292. PubMed ID: 23633329
[TBL] [Abstract][Full Text] [Related]
19. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
Al-Hendy A; Venturella R; Arjona Ferreira JC; Li Y; Soulban G; Wagman RB; Lukes AS
Am J Obstet Gynecol; 2023 Dec; 229(6):662.e1-662.e25. PubMed ID: 37666383
[TBL] [Abstract][Full Text] [Related]
20. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
Osuga Y; Enya K; Kudou K; Tanimoto M; Hoshiai H
Obstet Gynecol; 2019 Mar; 133(3):423-433. PubMed ID: 30741797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]